3c,d), which is not surprising as these doses far exceed the maximally efficacious doses of this GLP-1RA
In a May 1st announcement, GoodRx said eligible patients can obtain the oral GLP-1 therapy through its nationwide pharmacy network using transparent, self-pay pricing tiers. The program is positioned as a direct-to-patient access pathway outside of traditional insurance adjudication, with an emphasis on affordability and predictable out-of-pocket costs
It also means that the exact hour of injection matters less than it would for a short-acting drug
For instance, the SUSTAIN trial programme for semaglutide in type 2 diabetes demonstrated HbA1c reductions of 1.01.8% and weight loss of 3.56.5 kg at doses of 0.51.0 mg weekly
One 2025 pooled analysis reported a fasting glucose reduction of around 0.5 mmol/L and a larger drop in two-hour post-meal glucose
It's about understanding how to build meals that work with your body's own fullness signals